Lisa Jenkins | fatcat!

Given name	Lisa
Surname	Jenkins

Releases

This creator has contributed to:

2018-08-24	The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding published \| article-journal doi:10.1074/jbc.ra118.003525
2020-01-16	Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis published \| article-journal doi:10.1038/s41467-019-14085-2
2019-10-06	Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate published \| article-journal doi:10.1074/jbc.ra119.009269
2020-01-07	The RepID–CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation published \| article-journal doi:10.1038/s41467-019-13808-9
2020-05-11	An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes published \| article-journal doi:10.4049/jimmunol.2000165
2020-10-31	High Sensitivity Protein Gel Electrophoresis Label Compatible with Mass-Spectrometry published \| article-journal \| CC-BY doi:10.3390/bios10110160
2021-02-03	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors published \| article-journal \| CC-BY-NC-ND doi:10.1073/pnas.2015654118
2021-04-16	SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243 published \| article-journal doi:10.1158/0008-5472.can-20-2694
2020-11-13	A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation published \| article-journal \| CC-BY-NC doi:10.1126/sciadv.aba6290
2022-03-07	Author response: The TFIIH complex is required to establish and maintain mitotic chromosome structure unknown status \| peer_review \| CC-0 doi:10.7554/elife.75475.sa2
2022-06-10	NuRD complex recruitment to Thpok mediates CD4+ T cell lineage differentiation published \| article-journal doi:10.1126/sciimmunol.abn5917
2022-11-29	KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma. unknown status \| post \| CC-BY doi:10.21203/rs.3.rs-2298627/v1
2023	Publisher Correction: Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques published \| unknown type doi:10.1038/s41564-023-01412-z
2023-06-20	J-domain Proteins form Binary Complexes with Hsp90 and Ternary Complexes with Hsp90 and Hsp70 published \| article-journal doi:10.1016/j.jmb.2023.168184
2023-11-18	The TDRD3-USP9X complex and MIB1 regulate TOP3B homeostasis and prevent deleterious TOP3B cleavage complexes published \| article-journal \| CC-BY doi:10.1038/s41467-023-43151-z
2023-11-17	The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across species published \| post doi:10.1101/2023.11.17.567538
2024-01-15	Extracellular Proximity Labeling Reveals an Expanded Interactome for the Matrisome Protein TIMP2 published \| post \| CC-BY doi:10.21203/rs.3.rs-3857263/v1
2023-04-06	Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques published \| article-journal doi:10.1038/s41564-023-01353-7
2024-02-24	KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma published \| article-journal \| CC-BY doi:10.1038/s41467-024-45902-y
2024-02-28	A spatial map of hepatic mitochondria uncovers functional heterogeneity shaped by nutrient-sensing signaling published \| article-journal doi:10.1038/s41467-024-45751-9
2024-03-11	The novel ATR inhibitor M1774 induces replication protein overexpression and broad synergy with DNA-targeted anticancer drugs published \| article-journal doi:10.1158/1535-7163.mct-23-0402
2024-03-20	MANCR lncRNA modulates cell-cycle progression and metastasis by cis-regulation of nuclear <i>Rho-GEF</i> published \| dataset \| CC-BY doi:10.6084/m9.figshare.25439497
2024-03-20	MANCR lncRNA modulates cell-cycle progression and metastasis by cis-regulation of nuclear <i>Rho-GEF</i> published \| dataset \| v1 \| CC-BY doi:10.6084/m9.figshare.25439497.v1
2024-03-20	The homeobox transcription factor DUXBL controls exit from totipotency published \| article-journal doi:10.1038/s41588-024-01692-z
2024-07-02	Supplementary Figure S6 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145183
2024-07-02	Supplementary Figure S3 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145192.v1
2024-07-02	Supplementary Data set 1 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145201
2024-07-02	Supplementary Figure S1 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145198
2024-07-02	Supplementary Figure S5 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145186
2024-07-02	Data from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.c.7311489.v1
2024-07-05	Supplementary Figure S5 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190702.v1
2024-07-05	Supplementary Figure S7 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190696.v1
2024-07-05	Supplementary Figure S1 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190717
2024-07-05	Supplementary Figure S2 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190714.v1
2024-07-05	Supplementary Figure S1 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190717.v1
2024-07-05	Supplementary Figure S3 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190708.v1
2024-10-18	Altruistic feeding and cell-cell signaling during bacterial differentiation actively enhance phenotypic heterogeneity published \| article-journal doi:10.1126/sciadv.adq0791
2024-10-10	SMARCD1 is an essential expression-restricted metastasis modifier published \| article-journal doi:10.1038/s42003-024-07018-3
2022-03-16	The TFIIH complex is required to establish and maintain mitotic chromosome structure published \| article-journal \| CC-0 doi:10.7554/elife.75475
2023-03-31	Data from SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243 unknown status \| post \| CC-BY doi:10.1158/0008-5472.c.6513573
2024-05-31	Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate published \| article-journal doi:10.1038/s41467-024-49029-y
2018-06-08	Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals published \| article-journal doi:10.1083/jcb.201710170
2024-07-02	Supplementary Figure S4 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145189
2024-07-02	Supplementary Figure S7 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145180.v1
2024-07-02	Data from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.c.7311489
2024-07-02	Supplementary Figure S7 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145180
2024-07-02	Supplementary Figure S5 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145186.v1
2024-07-02	Supplementary Figure S1 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145198.v1
2024-07-05	Supplementary Figure S6 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190699.v1
2024-07-05	Supplementary Figure S5 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190702
2024-07-05	Supplementary Figure S4 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190705
2024-07-05	Supplementary Data set 1 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190720
2024-07-05	Supplementary Figure S3 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190708
2023-12-28	The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors published \| article-journal doi:10.1158/1535-7163.mct-23-0144
2024-10-14	Covalent Modification of p53 by (<i>E</i>)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one published \| article-journal doi:10.1021/acsptsci.4c00447
2025-01-29	Hsp90, DnaK, and ClpB collaborate in protein reactivation published \| article-journal doi:10.1073/pnas.2422640122
2023-03-31	Data from SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243 unknown status \| post \| CC-BY doi:10.1158/0008-5472.c.6513573.v1
2024-07-02	Supplementary Figure S6 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145183.v1
2024-07-02	Supplementary Figure S2 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145195.v1
2024-07-02	Supplementary Figure S3 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145192
2024-07-02	Supplementary Data set 1 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145201.v1
2024-07-02	Supplementary Figure S2 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145195
2024-07-02	Supplementary Figure S4 from The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26145189.v1
2024-07-05	Supplementary Figure S7 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190696
2024-07-05	Supplementary Data set 1 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190720.v1
2024-07-05	Supplementary Figure S6 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190699
2024-07-05	Supplementary Figure S2 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190714
2024-07-05	Supplementary Figure S4 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs unknown status \| post \| CC-BY doi:10.1158/1535-7163.26190705.v1
2024	The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer published \| article-journal \| CC-BY-NC-ND doi:10.1016/j.canlet.2024.217129
2025-01-10	Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms published \| article-journal doi:10.1126/sciadv.ads2919
2024-10-15	Bacterial spore surface nanoenvironment requires a AAA+ ATPase to promote MurG function published \| article-journal doi:10.1073/pnas.2414737121

ORCID^? 0000-0003-1245-1338

Lookup Links
wikidata.org
VIAF
dblp (CS)
Google Scholar

Catalog Record
Revision: c61f7970-9ff7-4449-9eb8-89912716b6a6
API URL: JSON

Lisa Jenkins creator_roklth7s3vbwbfk6yk623vhav4

Releases

Lisa Jenkins `creator_roklth7s3vbwbfk6yk623vhav4`